CeriBell, Inc. Financing Cash Flow
CeriBell, Inc. (CBLL) reported Financing Cash Flow of $2.51 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-10
- CeriBell, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $880.00K, a 56.13% decline year-over-year.
- CeriBell, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $1.63M, a 81500.00% increase year-over-year.
- CeriBell, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $1.40M, a 99.26% decline year-over-year.
- CeriBell, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $1.64M.
- CeriBell, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $5.05M, a 97.43% decline from fiscal 2024.
- CeriBell, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $196.52M.
- CeriBell, Inc. net cash provided by (used in) financing activities for fiscal 2023 was -$2.82M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $880.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $2.51M 10-Q · filed 2026-08-10 | $3.92M derived: sum of 3 quarters · filed 2026-08-10 | $5.55M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $1.63M 10-Q · filed 2026-05-11 | $3.04M derived: sum of 2 quarters · filed 2026-05-11 | $4.67M derived: sum of 3 quarters · filed 2026-05-11 | $6.68M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.04M derived: sum of 2 quarters · filed 2026-02-24 | $5.05M derived: sum of 3 quarters · filed 2026-08-10 | $5.05M 10-K · filed 2026-02-24 |
| 2025-09-30 | $1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $3.65M derived: sum of 2 quarters · filed 2026-08-10 | $3.65M 10-Q · filed 2025-11-04 | $194.38M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $2.01M 10-Q · filed 2026-08-10 | $192.74M derived: sum of 3 quarters · filed 2026-08-10 | $190.85M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $2.00K 10-Q · filed 2026-05-11 | $190.73M derived: sum of 2 quarters · filed 2026-05-11 | $188.84M derived: sum of 3 quarters · filed 2026-05-11 | $188.84M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $190.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $188.84M derived: sum of 2 quarters · filed 2026-02-24 | $188.84M derived: sum of 3 quarters · filed 2026-02-24 | $196.52M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$1.89M derived: sum of 2 quarters · filed 2025-11-04 | $5.79M 10-Q · filed 2025-11-04 | $2.33M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $7.68M 10-Q · filed 2025-08-05 | $4.21M derived: sum of 3 quarters · filed 2025-08-05 | |
| 2024-03-31 | $7.68M 10-Q · filed 2025-05-08 | $4.22M derived: sum of 2 quarters · filed 2025-05-08 | ||
| 2023-12-31 | -$3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$2.82M 10-K · filed 2025-02-25 | ||
| 2023-09-30 | $644.00K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |